{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:49:01Z","timestamp":1784735341560,"version":"3.55.0"},"reference-count":49,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Swedish Cancer Society","award":["20 1024 PjF, 2017\/404"],"award-info":[{"award-number":["20 1024 PjF, 2017\/404"]}]},{"name":"the Swedish Cancer Society","award":["PR2019-0019"],"award-info":[{"award-number":["PR2019-0019"]}]},{"name":"the Swedish Cancer Society","award":["PR2016-0038"],"award-info":[{"award-number":["PR2016-0038"]}]},{"name":"the Swedish Cancer Society","award":["21 1632 Pj 01 H"],"award-info":[{"award-number":["21 1632 Pj 01 H"]}]},{"name":"the Swedish Cancer Society","award":["2017-01658"],"award-info":[{"award-number":["2017-01658"]}]},{"name":"the Swedish Childhood Cancer Fund","award":["20 1024 PjF, 2017\/404"],"award-info":[{"award-number":["20 1024 PjF, 2017\/404"]}]},{"name":"the Swedish Childhood Cancer Fund","award":["PR2019-0019"],"award-info":[{"award-number":["PR2019-0019"]}]},{"name":"the Swedish Childhood Cancer Fund","award":["PR2016-0038"],"award-info":[{"award-number":["PR2016-0038"]}]},{"name":"the Swedish Childhood Cancer Fund","award":["21 1632 Pj 01 H"],"award-info":[{"award-number":["21 1632 Pj 01 H"]}]},{"name":"the Swedish Childhood Cancer Fund","award":["2017-01658"],"award-info":[{"award-number":["2017-01658"]}]},{"DOI":"10.13039\/501100002794","name":"the Swedish Cancer Society","doi-asserted-by":"publisher","award":["20 1024 PjF, 2017\/404"],"award-info":[{"award-number":["20 1024 PjF, 2017\/404"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"the Swedish Cancer Society","doi-asserted-by":"publisher","award":["PR2019-0019"],"award-info":[{"award-number":["PR2019-0019"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"the Swedish Cancer Society","doi-asserted-by":"publisher","award":["PR2016-0038"],"award-info":[{"award-number":["PR2016-0038"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"the Swedish Cancer Society","doi-asserted-by":"publisher","award":["21 1632 Pj 01 H"],"award-info":[{"award-number":["21 1632 Pj 01 H"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"the Swedish Cancer Society","doi-asserted-by":"publisher","award":["2017-01658"],"award-info":[{"award-number":["2017-01658"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["20 1024 PjF, 2017\/404"],"award-info":[{"award-number":["20 1024 PjF, 2017\/404"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["PR2019-0019"],"award-info":[{"award-number":["PR2019-0019"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["PR2016-0038"],"award-info":[{"award-number":["PR2016-0038"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["21 1632 Pj 01 H"],"award-info":[{"award-number":["21 1632 Pj 01 H"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2017-01658"],"award-info":[{"award-number":["2017-01658"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Chinese Scholarship Council","award":["20 1024 PjF, 2017\/404"],"award-info":[{"award-number":["20 1024 PjF, 2017\/404"]}]},{"name":"the Chinese Scholarship Council","award":["PR2019-0019"],"award-info":[{"award-number":["PR2019-0019"]}]},{"name":"the Chinese Scholarship Council","award":["PR2016-0038"],"award-info":[{"award-number":["PR2016-0038"]}]},{"name":"the Chinese Scholarship Council","award":["21 1632 Pj 01 H"],"award-info":[{"award-number":["21 1632 Pj 01 H"]}]},{"name":"the Chinese Scholarship Council","award":["2017-01658"],"award-info":[{"award-number":["2017-01658"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Mantle cell lymphoma (MCL) is a non-Hodgkin lymphoma with one of the highest male-to-female incidence ratios. The reason for this is not clear, but epidemiological as well as experimental data have suggested a role for estrogens, particularly acting through estrogen receptor \u03b2 (ESR2). To study the ESR2 effects on MCL progression, MCL cells sensitive and resistant to the Bruton tyrosine kinase inhibitor ibrutinib were grafted to mice and treated with the ESR2-selective agonist diarylpropionitrile (DPN). The results showed that the DPN treatment of mice grafted with both ibrutinib-sensitive and -resistant MCL tumors resulted in impaired tumor progression. To identify the signaling pathways involved in the impaired tumor progression following ESR2 agonist treatment, the transcriptome and ESR2 binding to target genes were investigated by genome-wide chromatin immunoprecipitation in Granta-519 MCL tumors. DPN-regulated genes were enriched in several biological processes that included cell\u2013cell adhesion, endothelial\u2013mesenchymal transition, nuclear factor-kappaB signaling, vasculogenesis, lymphocyte proliferation, and apoptosis. In addition, downregulation of individual genes, such as SOX11 and MALAT1, that play a role in MCL progression was also observed. Furthermore, the data suggested an interplay between the lymphoma cells and the tumor microenvironment in response to the ESR2 agonist. In conclusion, the results clarify the mechanisms by which estrogens, via ESR2, impair MCL tumor progression and provide a possible explanation for the sex-dependent difference in incidence. Furthermore, targeting ESR2 with a selective agonist may be an additional option when considering the treatment of both ibrutinib-sensitive and -resistant MCL tumors.<\/jats:p>","DOI":"10.3390\/cancers14133098","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T10:39:13Z","timestamp":1656153553000},"page":"3098","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Estrogen Receptor \u03b2 (ESR2) Transcriptome and Chromatin Binding in a Mantle Cell Lymphoma Tumor Model Reveal the Tumor-Suppressing Mechanisms of Estrogens"],"prefix":"10.3390","volume":"14","author":[{"given":"Dan","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5208-008X","authenticated-orcid":false,"given":"Zhiqiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-842X","authenticated-orcid":false,"given":"Rajitha","family":"Indukuri","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"},{"name":"Department of Protein Science, Science for Life Laboratory, KTH Royal Institute of Technology, SE-171 21 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekar","family":"Bangalore Revanna","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Berglund","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Yakimchuk","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Damdimopoulos","sequence":"additional","affiliation":[{"name":"Bioinformatics and Expression Core Facility, Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0602-2062","authenticated-orcid":false,"given":"Cecilia","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"},{"name":"Department of Protein Science, Science for Life Laboratory, KTH Royal Institute of Technology, SE-171 21 Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0822-1847","authenticated-orcid":false,"given":"Sam","family":"Okret","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, SE-141 83 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"ref_1","unstructured":"Sapkota, S., and Shaikh, H. (2022). Non-Hodgkin Lymphoma, StatPearls [Internet]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: Results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1182\/blood-2014-03-559930","article-title":"Real world data on primary treatment for mantle cell lymphoma: A Nordic Lymphoma Group observational study","volume":"124","author":"Abrahamsson","year":"2014","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1530\/EC-18-0459","article-title":"Suppression of lymphoma growth by the xenoestrogens bisphenol A and genistein","volume":"7","author":"Yakimchuk","year":"2018","journal-title":"Endocr. Connect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1016\/j.esmoop.2020.100001","article-title":"Sex as decisive variable in lymphoid neoplasms\u2014an update","volume":"6","author":"Vanura","year":"2021","journal-title":"ESMO Open"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/me.2010-0425","article-title":"Multiple Sequence-Specific DNA-Binding Proteins Mediate Estrogen Receptor Signaling through a Tethering Pathway","volume":"25","author":"Heldring","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/path.1883","article-title":"Differential expression of oestrogen receptors in human secondary lymphoid tissues","volume":"208","author":"Shim","year":"2005","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.1038\/ncomms15840","article-title":"Insufficient antibody validation challenges oestrogen receptor beta research","volume":"8","author":"Andersson","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"579420","DOI":"10.3389\/fendo.2020.579420","article-title":"G Protein-Coupled Estrogen Receptor in Immune Cells and Its Role in Immune-Related Diseases","volume":"11","author":"Notas","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.3324\/haematol.2015.127399","article-title":"The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cells","volume":"100","author":"Rudelius","year":"2015","journal-title":"Haematologica"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11357-018-0038-7","article-title":"Effects of long-term dietary administration of estrogen receptor-beta agonist diarylpropionitrile on ovariectomized female ICR (CD-1) mice","volume":"40","author":"Said","year":"2018","journal-title":"GeroScience"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"472720","DOI":"10.1155\/2013\/472720","article-title":"G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth","volume":"2013","author":"Petrie","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mce.2013.05.016","article-title":"Estrogen receptor alpha and beta in the normal immune system and in lymphoid malignancies","volume":"375","author":"Yakimchuk","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood-2013-07-517292","article-title":"Inhibition of lymphoma vascularization and dissemination by estrogen receptor beta agonists","volume":"123","author":"Yakimchuk","year":"2014","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/1535-7163.MCT-17-0784","article-title":"p110\u03b1 Inhibition Overcomes Stromal Cell\u2013Mediated Ibrutinib Resistance in Mantle Cell Lymphoma","volume":"17","author":"Guan","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.33573","article-title":"Genome-wide estrogen receptor beta chromatin binding in human colon cancer cells reveals its tumor suppressor activity","volume":"149","author":"Indukuri","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma","volume":"20","author":"Rahal","year":"2014","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3389\/fimmu.2018.01286","article-title":"seq-ImmuCC: Cell-Centric View of Tissue Transcriptome Measuring Cellular Compositions of Immune Microenvironment From Mouse RNA-Seq Data","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results from Randomized Trials of the European Mantle Cell Lymphoma Network","volume":"34","author":"Hoster","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-018-0621-5","article-title":"NF-kappaB signaling and its relevance to the treatment of mantle cell lymphoma","volume":"11","author":"Balaji","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/7410","article-title":"Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB","volume":"5","author":"Wang","year":"1999","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","article-title":"Pathogenic role of B-cell receptor signaling and canonical NF-kappaB activation in mantle cell lymphoma","volume":"128","author":"Saba","year":"2016","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V95.6.1900","article-title":"Cell adhesion receptors in lymphoma dissemination","volume":"95","author":"Drillenburg","year":"2000","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/bloodadvances.2020001665","article-title":"Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2","volume":"5","author":"Wu","year":"2021","journal-title":"Blood Adv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12929-018-0440-6","article-title":"Emerging roles of epithelial-mesenchymal transition in hematological malignancies","volume":"25","author":"Chen","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1878-0261.12085","article-title":"EMT- and MET-related processes in nonepithelial tumors: Importance for disease progression, prognosis, and therapeutic opportunities","volume":"11","author":"Kahlert","year":"2017","journal-title":"Mol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor Immune Microenvironment during Epithelial\u2013Mesenchymal Transition","volume":"27","author":"Taki","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hass, R., Von Der Ohe, J., and Ungefroren, H. (2020). The Intimate Relationship among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes. Cancers, 12.","DOI":"10.3390\/cancers12123674"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102113","DOI":"10.1016\/j.isci.2021.102113","article-title":"Interplay between tumor microenvironment and partial EMT as the driver of tumor progression","volume":"24","author":"Aggarwal","year":"2021","journal-title":"iScience"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-3173","article-title":"Molecular Pathways: Linking Tumor Microenvironment to Epithelial\u2013Mesenchymal Transition in Metastasis","volume":"21","author":"Jung","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOH.0000000000000434","article-title":"SOX11, a key oncogenic factor in mantle cell lymphoma","volume":"25","author":"Beekman","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2018-02-832535","article-title":"SOX11 augments BCR signaling to drive MCL-like tumor development","volume":"131","author":"Kuo","year":"2018","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): Importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-016-1100-9","article-title":"LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2","volume":"14","author":"Wang","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12935-020-1158-6","article-title":"MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma","volume":"20","author":"Qian","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-018-0656-7","article-title":"The lncRNA NEAT1 activates Wnt\/beta-catenin signaling and promotes colorectal cancer progression via interacting with DDX5","volume":"11","author":"Zhang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tem.2005.01.004","article-title":"Transcription factor cross-talk: The estrogen receptor and NF-kappaB","volume":"16","author":"Kalaitzidis","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr3196","article-title":"The interaction between ER and NFkappaB in resistance to endocrine therapy","volume":"14","author":"Sas","year":"2012","journal-title":"Breast Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/carcin\/bgs223","article-title":"Interplay between AP-1 and estrogen receptor \u03b1 in regulating gene expression and proliferation networks in breast cancer cells","volume":"33","author":"Qiao","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1158\/0008-5472.CAN-09-4407","article-title":"Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res."},{"key":"ref_44","first-page":"3","article-title":"RUNX family: Oncogenes or tumor suppressors (Review)","volume":"42","author":"Rojas","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"25332","DOI":"10.18632\/oncotarget.25011","article-title":"The B cell receptor signaling pathway in mantle cell lymphoma","volume":"9","author":"Merolle","year":"2018","journal-title":"Oncotarget"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"764727","DOI":"10.3389\/fcell.2021.764727","article-title":"Transforming Growth Factor-beta: An Agent of Change in the Tumor Microenvironment","volume":"9","author":"Stuelten","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Falcao","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGFbeta biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/13\/3098\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:39:09Z","timestamp":1760139549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/13\/3098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":49,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["cancers14133098"],"URL":"https:\/\/doi.org\/10.3390\/cancers14133098","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]}}}